| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Litton Mark James | CEO | Jan 05, 2024 | Sale | $2.91 | 4,820 | 14,026 | 144,397 | Feb 16, 2024, 04:38 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Executive Officer | Jan 05, 2024 | Sale | $2.91 | 4,820 | 14,026 | 144,397 | Jan 08, 2024, 04:40 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Executive Officer | Nov 18, 2022 | Option Exercise | $2.74 | 662 | 1,814 | 129,217 | Jan 31, 2023, 07:33 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Executive Officer | May 18, 2022 | Option Exercise | $7.06 | 757 | 5,344 | 116,515 | Jun 24, 2022, 07:51 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Executive Officer | Jun 23, 2022 | Sale | $2.69 | 7,960 | 21,412 | 128,555 | Jun 24, 2022, 07:51 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Executive Officer | Nov 18, 2021 | Option Exercise | $12.51 | 885 | 11,071 | 115,758 | Jan 31, 2022, 05:06 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Operating Officer | May 18, 2021 | Option Exercise | $14.45 | 867 | 12,528 | 64,433 | Aug 19, 2021, 05:05 PM | |
| ATHA | Athira Pharma, Inc. | Litton Mark James | Chief Operating Officer | Aug 17, 2021 | Option Exercise | $1.35 | 50,440 | 68,094 | 114,873 | Aug 19, 2021, 05:05 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jun 01, 2018 | Sale | $9.41 | 45,454 | 427,911 | 124,916 | Jun 05, 2018, 05:40 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Nov 13, 2017 | Option Exercise | $6.23 | 33,038 | 205,742 | 116,451 | Nov 15, 2017, 05:54 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Oct 16, 2017 | Option Exercise | $6.99 | 33,040 | 230,961 | 116,452 | Oct 18, 2017, 06:20 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 18, 2017 | Sale | $12.37 | 2,996 | 37,070 | 101,430 | Jan 20, 2017, 06:38 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 05, 2017 | Option Exercise | $12.13 | 4,432 | 53,775 | 102,148 | Jan 09, 2017, 05:49 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 06, 2017 | Sale | $12.18 | 13,600 | 165,632 | 106,732 | Jan 09, 2017, 05:49 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 09, 2017 | Sale | $12.32 | 1,000 | 12,325 | 100,432 | Jan 09, 2017, 05:49 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Oct 17, 2016 | Sale | $27.50 | 6,000 | 164,998 | 26,000 | Oct 19, 2016, 05:51 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jul 12, 2016 | Option Exercise | $0.38 | 25,000 | 9,625 | 99,567 | Jul 14, 2016, 07:14 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jun 13, 2016 | Sale | $28.94 | 6,000 | 173,664 | 28,200 | Jun 15, 2016, 07:02 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | May 27, 2016 | Sale | $15.22 | 10,560 | 160,726 | 79,847 | Jun 01, 2016, 07:49 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | May 31, 2016 | Sale | $15.22 | 39,440 | 600,158 | 94,287 | Jun 01, 2016, 07:49 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 04, 2016 | Sale | $15.89 | 50,000 | 794,576 | 98,718 | Jan 06, 2016, 08:40 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Oct 01, 2015 | Sale | $32.27 | 7,500 | 242,002 | 73,479 | Oct 05, 2015, 06:19 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Sep 24, 2015 | Option Exercise | $1.26 | 12,764 | 16,146 | 80,419 | Sep 28, 2015, 06:11 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jul 01, 2015 | Sale | $51.10 | 7,500 | 383,219 | 67,655 | Jul 06, 2015, 05:59 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jun 04, 2015 | Option Exercise | $22.33 | 50,000 | 1,116,478 | 100,155 | Jun 08, 2015, 07:05 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Apr 01, 2015 | Sale | $27.41 | 7,500 | 205,552 | 74,359 | Apr 03, 2015, 05:58 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 26, 2015 | Sale | $28.03 | 5,200 | 145,732 | 84,159 | Jan 28, 2015, 05:56 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Jan 27, 2015 | Sale | $28.52 | 2,300 | 65,602 | 81,859 | Jan 28, 2015, 05:56 PM | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | Litton Mark James | Chief Business Officer | Nov 20, 2014 | Sale | $15.63 | 30,000 | 469,011 | 88,484 | Nov 24, 2014, 06:37 PM |
Menu